Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. Signal., 9 February 2010
Vol. 3, Issue 108, p. ra10
[DOI: 10.1126/scisignal.2000628]

RESEARCH ARTICLES

SUMOylation Mediates the Nuclear Translocation and Signaling of the IGF-1 Receptor

Bita Sehat1, Ali Tofigh2*, Yingbo Lin1*, Eric Trocmé1, Ulrika Liljedahl3, Jens Lagergren2, and Olle Larsson1{dagger}

1 Department of Oncology and Pathology, Karolinska Institutet, Cancer Center Karolinska, R8:04, Karolinska University Hospital, SE-171 76 Stockholm, Sweden.
2 KTH Royal Institute of Technology, Computational Biology, Stockholm Bioinformatics Centre, SE-100 44 Stockholm, Sweden.
3 Department of Medical Sciences, Uppsala University, SE-751 85 Uppsala, Sweden.

* These authors contributed equally to this work.

Abstract: The insulin-like growth factor 1 receptor (IGF-1R) plays crucial roles in developmental and cancer biology. Most of its biological effects have been ascribed to its tyrosine kinase activity, which propagates signaling through the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways. Here, we report that IGF-1 promotes the modification of IGF-1R by small ubiquitin-like modifier protein–1 (SUMO-1) and its translocation to the nucleus. Nuclear IGF-1R associated with enhancer-like elements and increased transcription in reporter assays. The SUMOylation sites of IGF-1R were identified as three evolutionarily conserved lysine residues—Lys1025, Lys1100, and Lys1120—in the β subunit of the receptor. Mutation of these SUMO-1 sites abolished the ability of IGF-1R to translocate to the nucleus and activate transcription but did not alter its kinase-dependent signaling. Thus, we demonstrate a SUMOylation-mediated mechanism of IGF-1R signaling that has potential implications for gene regulation.

{dagger} To whom correspondence should be addressed. E-mail: Olle.Larsson{at}ki.se

Citation: B. Sehat, A. Tofigh, Y. Lin, E. Trocmé, U. Liljedahl, J. Lagergren, O. Larsson, SUMOylation Mediates the Nuclear Translocation and Signaling of the IGF-1 Receptor. Sci. Signal. 3, ra10 (2010).

Read the Full Text

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Insulin-like Growth Factor-I Receptor (IGF-IR) Translocates to Nucleus and Autoregulates IGF-IR Gene Expression in Breast Cancer Cells.
R. Sarfstein, M. Pasmanik-Chor, A. Yeheskel, L. Edry, N. Shomron, N. Warman, E. Wertheimer, S. Maor, L. Shochat, and H. Werner (2012)
J. Biol. Chem. 287, 2766-2776
   Abstract »    Full Text »    PDF »
Protein localization in disease and therapy.
M.-C. Hung and W. Link (2011)
J. Cell Sci. 124, 3381-3392
   Abstract »    Full Text »    PDF »
Signalling by insulin and IGF receptors: supporting acts and new players.
K. Siddle (2011)
J. Mol. Endocrinol. 47, R1-R10
   Abstract »    Full Text »    PDF »
The Translocon Sec61{beta} Localized in the Inner Nuclear Membrane Transports Membrane-embedded EGF Receptor to the Nucleus.
Y.-N. Wang, H. Yamaguchi, L. Huo, Y. Du, H.-J. Lee, H.-H. Lee, H. Wang, J.-M. Hsu, and M.-C. Hung (2010)
J. Biol. Chem. 285, 38720-38729
   Abstract »    Full Text »    PDF »
Small Is Beautiful: Insulin-Like Growth Factors and Their Role in Growth, Development, and Cancer.
R. G. Maki (2010)
J. Clin. Oncol. 28, 4985-4995
   Abstract »    Full Text »    PDF »
Type 1 Insulin-like Growth Factor Receptor Translocates to the Nucleus of Human Tumor Cells.
T. Aleksic, M. M. Chitnis, O. V. Perestenko, S. Gao, P. H. Thomas, G. D. Turner, A. S. Protheroe, M. Howarth, and V. M. Macaulay (2010)
Cancer Res. 70, 6412-6419
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882